Oyster Point Pharma Inc
Biotechnology
Healthcare
OYST
26.74 M shares
NASDAQ US
traded
30 Dec 2022
listed
yes
open
11.16
52 week high
18.96
high
11.20
52 week low
3.60
low
11.12
growth
-30.19 %
previous Close
11.17
P/E ratio
-6
market cap
186 M
div yield
0
usd
Jun 2022
qoq
revenue
4.69 M
0.00 %
net incoming
-49.94 M
0.00 %
eps
-1.87 %
-3.89 %
eps surprise
-12.65 %
net profit margin
-1064.18 %
-1064.00 %
operating incoming
-43.39 M
0.00 %
net change in cash
-38.49 M
0.00 %
cash on hand
105 M
0.00 %
cost of revenue
1.31 M
0.00 %
top top